Correspondingly, knockdown of CD44 with specific siRNA (small interfering RNA) in human colon cancer cells could dramatically suppresse cell growth and tumor progression in vitro and in vivo, strongly implying a potent regulator of CD44 in the progression of CRC [17, 18]. The gene discussed is CD44; the disease is neoplasm.